MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ctr.70493

Медицинская библиотека · Clinical transplantation · 2026

Impact of Pulmonary Veno-Occlusive Disease on Posttransplant Survival in Pulmonary Hypertension.

Manso Tejerina Pedro, Loaiza Quezada, Andrés Carlos, Margallo Iribarnegaray Juan, Pérez González Virginia Luz, Cruz Utrilla Alejandro, Escribano Subias María Pilar, Martín-Arriscado Arroba Cristina, Hermoso Alarza Fátima, Gámez García Antonio Pablo, González González Olga, López López Eloisa, De Pablo Gafas Alicia, Alonso Moralejo Rodrigo

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Pulmonary veno-occlusive disease (PVOD) is a rare but severe form of pulmonary arterial hypertension (PAH), characterized by poor response to medical therapy. Lung transplantation is often the only therapeutic alternative.

METHODS

We analyzed a retrospective cohort of 58 patients with group 1 PAH who underwent lung transplantation between 2011 and 2024. Baseline characteristics, perioperative complications, and survival were compared between patients with and without PVOD. Statistical methods included descriptive analysis, Kaplan-Meier survival curves, log-rank tests, and Cox regression.

RESULTS

Among the 58 patients, 21 (36.2%) had a diagnosis of PVOD before transplantation. PVOD patients were younger (median age 39.8 vs. 43.1 years, p = 0.03), had lower DLCO (32% vs. 66%, p < 0.001), shorter six-minute walk distance (300 vs. 430 m, p < 0.001), and a higher COMPERA 2.0 four-strata risk score (median 3 vs. 2, p = 0.035) tan non-PVOD patients. Hemodynamically, PVOD patients showed lower systolic pulmonary artery pressure (78 vs. 98 mmHg, p = 0.038), lower pulmonary vascular resistance (9.2 vs. 10.6 Wood units, p = 0.03), and lower right atrial pressure (6.5 vs. 11.5 mmHg, p = 0.003). Time from diagnosis to transplantation was significantly shorter (23.8 vs. 69.6 months, p < 0.001), and extracorporeal membrane oxygenation (ECMO) as bridge to transplantation was more frequent (23.8% vs. 2.7%, p = 0.011). Survival did not differ significantly between groups (log-rank p = 0.657). Postoperative need for non-invasive ventilation (NIV) was independently associated with mortality (HR 3.15; 95% CI 1.00-9.83; p = 0.042).

CONCLUSIONS

Lung transplantation in PVOD patients results in survival comparable to other group 1 PAH subtypes. Postoperative need for NIV identifies patients at higher risk of mortality.

Для цитирования: Manso Tejerina Pedro, Loaiza Quezada, Andrés Carlos, Margallo Iribarnegaray Juan, Pérez González Virginia Luz, Cruz Utrilla Alejandro, Escribano Subias María Pilar, Martín-Arriscado Arroba Cristina, Hermoso Alarza Fátima, Gámez García Antonio Pablo, González González Olga, López López Eloisa, De Pablo Gafas Alicia, Alonso Moralejo Rodrigo. Impact of Pulmonary Veno-Occlusive Disease on Posttransplant Survival in Pulmonary Hypertension.. Clinical transplantation. 2026. DOI: 10.1111/ctr.70493.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.